Backed by Apollo Health Ventures, Nula aims to transform treatment of metabolic dysfunctionARPA-H award brings total funding ...
In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...
Scientists are turning to AI and speech analysis to uncover early signs of Alzheimer’s in ways traditional methods may miss.
The Arkansas Supreme Court has upheld a lower court's denial of postconviction relief to Zachary Holly, a Benton County man ...
Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...
As GTM systems become more digital, data-driven, and interconnected, the need for integrated leadership have intensified- the ...
Cardiovascular Ultrasound System Market OverviewThe global cardiovascular ultrasound system market is projected to grow steadily over the coming years with an estimated compound annual growth rate of ...
MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity: Cambridge, Massachusetts Monday, April 13, 2026, 11:00 Hrs ...
Americans’ fatigue is rising as costs climb, crises multiply and leaders focus on spectacle instead of solutions. This exhaustion is not personal — it is political, weakening the Republic's ...
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesineConvergence of impaired ...
While protests draw attention to abuses, there remains only one true check on power: our right to vote.
VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results